Latest Stories

W
Three Reasons

3 Reasons WST is Risky and 1 Stock to Buy Instead

West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Dec 04, 2025
F
Three Reasons

3 Reasons to Avoid FSUN and 1 Stock to Buy Instead

Since June 2025, FirstSun Capital Bancorp has been in a holding pattern, posting a small loss of 0.7% while floating around $34.65. The stock also fell short of the S&P 500’s 14.4% gain during that period.

Dec 04, 2025
M
Three Reasons

MasTec (MTZ): Buy, Sell, or Hold Post Q3 Earnings?

MasTec currently trades at $218.54 and has been a dream stock for shareholders. It’s returned 249% since December 2020, tripling the S&P 500’s 84.3% gain. The company has also beaten the index over the past six months as its stock price is up 38.6% thanks to its solid quarterly results.

Dec 04, 2025
O
Three Reasons

3 Reasons to Avoid ORI and 1 Stock to Buy Instead

Old Republic International has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 18% to $44.15 per share while the index has gained 14.4%.

Dec 04, 2025
W
Three Reasons

3 Reasons to Sell WOW and 1 Stock to Buy Instead

Over the past six months, WideOpenWest has been a great trade, beating the S&P 500 by 8.6%. Its stock price has climbed to $5.19, representing a healthy 23% increase. This performance may have investors wondering how to approach the situation.

Dec 04, 2025
B
Three Reasons

3 Reasons to Sell BY and 1 Stock to Buy Instead

Byline Bancorp trades at $29.19 per share and has stayed right on track with the overall market, gaining 13.1% over the last six months. At the same time, the S&P 500 has returned 14.4%.

Dec 04, 2025
F
Three Reasons

3 Reasons to Avoid FA and 1 Stock to Buy Instead

What a brutal six months it’s been for First Advantage. The stock has dropped 23.4% and now trades at $13.95, rattling many shareholders. This may have investors wondering how to approach the situation.

Dec 04, 2025
U
Post-Earnings

Ground Transportation Stocks Q2 Teardown: Universal Logistics (NASDAQ:ULH) Vs The Rest

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Universal Logistics (NASDAQ:ULH) and the rest of the ground transportation stocks fared in Q2.

Dec 04, 2025
C
Post-Earnings

Q3 Earnings Review: Health Insurance Providers Stocks Led by CVS Health (NYSE:CVS)

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.

Dec 04, 2025
M
Post-Earnings

A Look Back at Social Networking Stocks’ Q3 Earnings: Meta (NASDAQ:META) Vs The Rest Of The Pack

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at social networking stocks, starting with Meta (NASDAQ:META).

Dec 04, 2025